Get the Stockscreener App
1.99
2.05%
0.04
After Hours:
2.02
0.03
+1.51%
Filana Therapeutics Inc stock is traded at $1.99, with a volume of 577.16K.
It is up +2.05% in the last 24 hours and up +0.00% over the past month.
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A.
See More
Previous Close:
$1.95
Open:
$2.04
24h Volume:
577.16K
Relative Volume:
28.30
Market Cap:
$96.13M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.95
$2.06
1-Week Range:
$1.95
$2.0901
52-Week Range:
$1.95
$2.0901
Filana Therapeutics Inc Stock (FLNA) Company Profile
Name
Filana Therapeutics Inc
Sector
Industry
Phone
-
Address
-
Compare FLNA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FLNA
Filana Therapeutics Inc
|
1.99 | 94.20M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Filana Therapeutics Inc Stock (FLNA) Financials Data
There is no financial data for Filana Therapeutics Inc (FLNA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.48%
1.21%
Cap:
|
Volume (24h):